Kent Edward Kester insider trades

Open-market stock purchases and sales by Kent Edward Kester, Director at Turn Therapeutics Inc, from SEC Form 4 filings since Oct 8, 2025.

Recent trades

DateStockTradeValue
Jun 4, 2026TTRX Turn Therapeutics IncBought (not open market)—
Oct 8, 2025TTRX Turn Therapeutics IncBought (not open market)—

Companies traded

  • TTRX Turn Therapeutics Inc: other filings, last Jun 4, 2026

Get free alerts when Kent Edward Kester files a new trade →